On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Betalin Therapeutics Ltd's own share of each project, not the project's full budget.
- Horizon 2020€3.7M · 3 projects
Projects
3 EU-funded projects, newest first. Betalin Therapeutics Ltd led 3 of them as coordinator. Each links to the official record.
- Micro PancreasCoordinator
Cure Diabetes by Injection of Micro Pancreas Cell Therapy
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€2.5Mtheir share - Cells in MatrixCoordinator
Cells in Matrix – an innovative 3D model for R&D of Diabetes
Horizon 2020 · 2020–2023 · Project on CORDIS ↗
€1.2Mtheir share - Io-EMPCoordinator
Tissue-derived acellular micro-scaffold technology reducing or eliminating diabetics’ dependence on insulin therapy
Horizon 2020 · 2017–2018 · Project on CORDIS ↗
€50ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Technische Universitaet DresdenGermany · 1 shared project
- Universitat ZurichSwitzerland · 1 shared project
- Kugelmeiers AGSwitzerland · 1 shared project
- Betalinuk LimitedUnited Kingdom · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- cells technologies
- cerebrovascular diseases
- diabetes
- diabetic nephropathy
- drug discovery
- immunology
- implants
- pharmaceutical drugs
- pharmacokinetics
- retinopathy
- stem cells
- stroke
- toxicology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.